Ironwood Pharmaceuticals Files 8-K Report
Ticker: IRWD · Form: 8-K · Filed: Apr 14, 2025 · CIK: 1446847
| Field | Detail |
|---|---|
| Company | Ironwood Pharmaceuticals Inc (IRWD) |
| Form Type | 8-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, exhibits
TL;DR
Ironwood Pharma filed an 8-K, mostly financial docs, no big news yet.
AI Summary
On April 14, 2025, Ironwood Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text.
Why It Matters
This filing indicates routine corporate reporting, likely related to financial statements or exhibits, without immediate news of major business developments.
Risk Assessment
Risk Level: low — The filing appears to be routine and does not disclose any new risks or significant negative events.
Key Players & Entities
- Ironwood Pharmaceuticals, Inc. (company) — Registrant
- 0001104659-25-034381 (document_id) — Accession Number
- April 14, 2025 (date) — Date of Report
- 100 Summer Street, Suite 2300 (address) — Principal Executive Offices
- Boston, Massachusetts (location) — City, State of Principal Executive Offices
- 02110 (zip_code) — Zip Code of Principal Executive Offices
- 617-621-7722 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The filing is primarily for reporting financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Financial Statements and Exhibits' section.
When was this 8-K report filed?
The report was filed on April 14, 2025.
What is Ironwood Pharmaceuticals, Inc.'s principal executive office address?
The principal executive offices are located at 100 Summer Street, Suite 2300, Boston, Massachusetts 02110.
What is the registrant's telephone number?
The registrant's telephone number, including area code, is (617) 621-7722.
Does this filing report any specific material events?
Based on the provided text, the filing is categorized under 'Other Events' and 'Financial Statements and Exhibits,' with no specific material events detailed.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).